https://www.selleckchem.com/TGF-beta.html
A simple, accurate, rapid and sensitive reversed-phase high-performance liquid chromatography (RP-HPLC) method was established for determination of a novel non-vitamin K antagonist oral anticoagulant drug, betrixaban, and its co-administered calcium-channel blocker drug, lercanidipine, in pharmaceutical formulations and biological fluids. The proposed HPLC method was the first chromatographic method applied to estimate this mixture in a short chromatographic run ( less then 6 min), high resolution between betrixaban/lercanidipine (Rs = 7.12) an
Like
Comment
Share
